Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Depletion of UBE2C reduces ovarian cancer malignancy and reverses cisplatin resistance via downregulating CDK1
Jiajia Li, Xiuling Zhi, Xiaoqing Shen, et al.
Biochemical and Biophysical Research Communications (2019) Vol. 523, Iss. 2, pp. 434-440
Closed Access | Times Cited: 47

Showing 1-25 of 47 citing articles:

Delineating the dynamic evolution from preneoplasia to invasive lung adenocarcinoma by integrating single-cell RNA sequencing and spatial transcriptomics
Jianfei Zhu, Yue Fan, Yanlu Xiong, et al.
Experimental & Molecular Medicine (2022) Vol. 54, Iss. 11, pp. 2060-2076
Open Access | Times Cited: 82
A review on the role of cyclin dependent kinases in cancers
Soudeh Ghafouri‐Fard, Tayyebeh Khoshbakht, Bashdar Mahmud Hussen, et al.
Cancer Cell International (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 81
Employing siRNA tool and its delivery platforms in suppressing cisplatin resistance: Approaching to a new era of cancer chemotherapy
Sepideh Mirzaei, Mohammad Gholami, Farid Hashemi, et al.
Life Sciences (2021) Vol. 277, pp. 119430-119430
Closed Access | Times Cited: 91
Patients with Cholangiocarcinoma Present Specific RNA Profiles in Serum and Urine Extracellular Vesicles Mirroring the Tumor Expression: Novel Liquid Biopsy Biomarkers for Disease Diagnosis
Ainhoa Lapitz, Ander Arbelaiz, Colm J. O’Rourke, et al.
Cells (2020) Vol. 9, Iss. 3, pp. 721-721
Open Access | Times Cited: 80
Comprehensive Pan-Cancer Analysis of the Prognostic and Immunological Roles of the METTL3/lncRNA-SNHG1/miRNA-140-3p/UBE2C Axis
Xiulin Jiang, Yixiao Yuan, Lin Tang, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 38
UBE2C affects breast cancer proliferation through the AKT/mTOR signaling pathway
Zinan Lu, Jia Song, Tong-Hui Sun, et al.
Chinese Medical Journal (2021) Vol. 134, Iss. 20, pp. 2465-2474
Open Access | Times Cited: 36
Ubiquitin conjugating enzyme E2 C (UBE2C) may play a dual role involved in the progression of thyroid carcinoma
Cheng Xiang, Haichao Yan
Cell Death Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 24
A compendium of Androgen Receptor Variant 7 target genes and their role in Castration Resistant Prostate Cancer
Katie Joanna Miller, Isla Henry, Zoe R. Maylin, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 14
UBE2C promotes the proliferation of acute myeloid leukemia cells through PI3K/AKT activation
Li Wang, Shuqin Zhao, Yongling Wang, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 6
UBE2C is a Potential Biomarker for Tumorigenesis and Prognosis in Tongue Squamous Cell Carcinoma
Pei‐Feng Liu, Hung-Chih Chen, Chih‐Wen Shu, et al.
Diagnostics (2020) Vol. 10, Iss. 9, pp. 674-674
Open Access | Times Cited: 30
The Molecular Basis of Ubiquitin-Conjugating Enzymes (E2s) as a Potential Target for Cancer Therapy
Xiaodi Du, Hongyu Song, Nengxing Shen, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 7, pp. 3440-3440
Open Access | Times Cited: 26
Prognostic Significance of CDK1 in Ovarian and Cervical Cancers
Xu Cong, Chao‐Wen Chen, Yonghong Xu, et al.
Journal of Cancer (2025) Vol. 16, Iss. 5, pp. 1656-1667
Open Access
UBE2C Mediates Follicular Thyroid Carcinoma Invasion and Metastasis via K29-Specific Vimentin Ubiquitination
Lei Xu, Bao Dai, Lingyun Zhang, et al.
Cancer Letters (2025), pp. 217624-217624
Closed Access
Integrating multi-omics and experimental techniques to decode ubiquitinated protein modifications in hepatocellular carcinoma
Haikun Yang, Yuan Chen, Zheng Zhou, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Direct cell interactions potentially regulate transcriptional programmes that control the responses of high grade serous ovarian cancer patients to therapy
Sodiq Ayobami Hameed, Walter Kölch, Donal J. Brennan, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
<p>Inhibition of CDK1 Reverses the Resistance of 5-Fu in Colorectal Cancer</p>
Yiping Zhu, Kai Li, Jieling Zhang, et al.
Cancer Management and Research (2020) Vol. Volume 12, pp. 11271-11283
Open Access | Times Cited: 26
Construction of novel mRNA-miRNA-lncRNA regulatory networks associated with prognosis of ovarian cancer
Lingling Gao, Xiao Li, Xin Nie, et al.
Journal of Cancer (2020) Vol. 11, Iss. 23, pp. 7057-7072
Open Access | Times Cited: 25
Interactive bioinformatics analysis for the screening of hub genes and molecular docking of phytochemicals present in kitchen spices to inhibit CDK1 in cervical cancer
Harsha Vaghasia, Shiralee Sakaria, Jignesh Prajapati, et al.
Computers in Biology and Medicine (2022) Vol. 149, pp. 105994-105994
Closed Access | Times Cited: 16
Role of UBE2C in Brain Cancer Invasion and Dissemination
Stefani Domentean, Eunice Paisana, Rita Cascão, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 21, pp. 15792-15792
Open Access | Times Cited: 9
UBE2C enhances temozolomide resistance by regulating the expression of p53 to induce aerobic glycolysis in glioma
Kun Zhou, Dexin Wang, Xiaolin Du, et al.
Acta Biochimica et Biophysica Sinica (2024)
Open Access | Times Cited: 3
Identification of transcriptome characteristics of granulosa cells and the possible role of UBE2C in the pathogenesis of premature ovarian insufficiency
Dan Liu, Xiaohong Guan, Wenqiang Liu, et al.
Journal of Ovarian Research (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 7
UBE2C promotes LUAD progression by ubiquitin-dependent degradation of p53 to inactivate the p53/p21 signaling pathway
Siyuan Huang, Xingya Li
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 2
Pentraxin 3 is a diagnostic and prognostic marker for ovarian epithelial cancer patients based on comprehensive bioinformatics and experiments
Xiaoying Chang, Dan Li, Chang Liu, et al.
Cancer Cell International (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 16
Mechanistic study of lncRNA UCA1 promoting growth and cisplatin resistance in lung adenocarcinoma
Jiali Fu, Jingjing Pan, Yang Xiang, et al.
Cancer Cell International (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 13
The Role of Rab GTPases in the development of genetic and malignant diseases
Özgür Doğuş Erol, Şimal Şenocak, Fatima Aerts‐Kaya
Molecular and Cellular Biochemistry (2023) Vol. 479, Iss. 2, pp. 255-281
Closed Access | Times Cited: 5
Page 1 - Next Page

Scroll to top